Spain Pharmaceutical Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Spain's Pharmaceutical Logistics Market Report is Segmented by Product(Generic Drugs, Branded Drugs), by Mode of Operation (Cold Chain Logistics, Non-Cold Chain Logistics), by Application (Bio-Pharma, Chemical Pharma), and by Mode of Transport (Air Shipping, Rail Shipping, Road Shipping, Sea Shipping). The Report Offers Market Size and Forecasts for the Spain Pharmaceutical Logistics Market in Value (USD) for all the Above Segments.

Spain Pharmaceutical Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Spain Pharmaceutical Logistics Market Size

Spain Pharmaceutical Logistics Market Summary
Study Period 2020 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 5.88 Billion
Market Size (2030) USD 7.29 Billion
CAGR (2025 - 2030) 4.40 %
Market Concentration Medium

Major Players

Spain Pharmaceutical Logistics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Spain Pharmaceutical Logistics Market with other markets in Logistics Industry

Freight Transport

Freight Transportation Arrangement

Courier Express Parcel

Integrated Logistics

Cold Chain Logistics

Customers of Logistics Services

Spain Pharmaceutical Logistics Market Analysis

The Spain Pharmaceutical Logistics Market size is estimated at USD 5.88 billion in 2025, and is expected to reach USD 7.29 billion by 2030, at a CAGR of greater than 4.4% during the forecast period (2025-2030).

Spain's pharmaceutical logistics sector has emerged as a crucial component of the country's industrial landscape, characterized by robust manufacturing capabilities and significant employment generation. The country currently operates 103 factories producing medicines for human use, with eleven facilities specifically dedicated to biologics manufacturing, demonstrating the sector's sophisticated infrastructure. The pharmaceutical industry has become a major economic contributor, generating approximately 183,000 jobs across direct, indirect, and induced employment categories. The sector's commitment to innovation is evident through substantial research and development investments, which reached EUR 1,267 million in 2021, marking a 9.2% increase from the previous year and highlighting the industry's focus on technological advancement and operational excellence.


The logistics infrastructure supporting Spain's pharmaceutical sector continues to evolve with significant investments in modern facilities and technological capabilities. In January 2023, Bomi Group inaugurated a state-of-the-art pharmaceutical warehousing and distribution facility in Madrid following an 18-million-euro investment, featuring 27,578m² of space and capacity for 60,000 pallets. This development is particularly significant as approximately 80% of pharmaceutical products in Europe now require pharmaceutical cold chain transportation, reflecting the growing complexity of pharmaceutical logistics operations. The facility incorporates various temperature-controlled storage solutions (-30°C, +2+8°C, +15+25°C) and houses an advanced automated order-picking system with an expected error rate of less than 0.02%.


The market is witnessing a transformation in pharmaceutical distribution patterns and service offerings, with companies expanding their presence and capabilities. In October 2023, Eurotranspharma strengthened its European network by establishing direct operations in Spain, utilizing a storage and transport hub in Numancia de la Sagra (Toledo) and 14 distribution platforms throughout the country. The generic drug segment has gained significant traction, with two out of every five pills sold in pharmacies being generic products, representing 21% of public pharmaceutical spending. This trend has important implications for logistics providers, who must adapt their operations to handle both branded and generic pharmaceutical products efficiently.


The industry is experiencing substantial infrastructure expansion and modernization initiatives. AGC Pharma Chemicals Europe announced a significant facility expansion in Spain, investing approximately EUR 95.11 million in a new 7,500 m² building to increase current production capacity by 30%. This expansion includes specialized facilities for highly potent active pharmaceutical ingredients (HPAPI), reflecting the growing demand for advanced pharmaceutical manufacturing and pharmaceutical supply chain capabilities. The development of such facilities demonstrates the industry's commitment to meeting evolving market demands while maintaining strict quality and safety standards in pharmaceutical logistics operations.

Segment Analysis: By Service

Transportation Segment in Spain Pharmaceutical Logistics Market

The pharmaceutical transportation segment dominates the Spanish pharmaceutical logistics market, commanding approximately 55% market share in 2024. This segment encompasses various modes of transport, including road, rail, air, and sea transportation services, with road transport being the predominant mode. The segment's strong position is supported by Spain's well-developed transportation infrastructure and strategic location as a key pharmaceutical hub in Europe. Major logistics providers like DHL, UPS, and Movianto have made significant investments in temperature-controlled vehicles and advanced tracking systems to ensure compliance with Good Distribution Practice (GDP) guidelines. The segment's dominance is further reinforced by the increasing demand for specialized pharmaceutical freight services, particularly for temperature-sensitive products and vaccines.

Market Analysis of Spain Pharmaceutical Logistics Market: Chart for By Service

Value Added Services Segment in Spain Pharmaceutical Logistics Market

The value-added services segment is emerging as the fastest-growing segment in the Spanish pharmaceutical logistics market, projected to grow at approximately 6.5% during 2024-2029. This growth is driven by increasing demand for specialized services such as packaging, labeling, order management, and quality control services. The segment's expansion is supported by the pharmaceutical industry's growing need for serialization services to comply with EU regulations and combat counterfeit medicines. Leading logistics providers are investing in advanced technologies and automated systems to enhance their value-added service offerings. The segment is also benefiting from the rise in e-commerce pharmaceutical sales, which requires additional services like order processing, returns management, and specialized packaging solutions.

Remaining Segments in By Service Segmentation

The storage and warehousing segment plays a crucial role in the Spanish pharmaceutical logistics market, offering specialized facilities for pharmaceutical storage at various temperature ranges. This segment has seen significant developments with companies like Bomi Group and Movianto expanding their warehouse facilities with state-of-the-art temperature control systems. The segment's importance is highlighted by the increasing demand for GDP-compliant storage facilities and the growing need for specialized handling of biopharmaceutical products. Modern warehouses are incorporating advanced automation technologies and real-time monitoring systems to ensure product integrity and compliance with regulatory requirements.

Segment Analysis: By Temperature Control

Non-temperature Controlled/Non-cold Chain Segment in Spain Pharmaceutical Logistics Market

The non-temperature controlled/non-cold chain segment dominates the Spanish pharmaceutical logistics market, holding approximately 61% market share in 2024. This segment primarily handles the transportation, storage, packaging, and labeling of products like generic and OTC (over-the-counter) drugs, including vitamins, minerals, supplements, common cough and cold drugs, dermatology products, and homeopathic medicines. Spain maintains a leadership position in the European vitamin supplements market, expected to hold around 21% of the entire European turnover in this sector. The increased consumer focus on boosting immunity and overall health has significantly boosted the demand for dietary and health supplements across Spain, driving the growth of this segment. Various large and small food and vitamin supplement retailers have reported a substantial surge in demand for supplements, necessitating robust non-temperature controlled logistics infrastructure and services.

Temperature Controlled/Cold Chain Segment in Spain Pharmaceutical Logistics Market

The pharmaceutical cold chain segment is projected to experience the fastest growth rate of approximately 6% during 2024-2029, driven by increasing demand for specialized pharmaceutical logistics services. This growth is primarily attributed to the rising need for temperature-sensitive product handling, particularly in the biopharmaceutical sector. The segment has witnessed significant investments in infrastructure development, with companies like Bomi Group establishing new storage and distribution facilities in Madrid featuring various temperature-controlled storage solutions (-30°C, +2+8°C, +15+25°C). The increasing complexity of pharmaceutical products, particularly biologics and specialty medicines, has necessitated more sophisticated pharma cold chain solutions. Currently, about 80% of pharmaceutical products in Europe require temperature-controlled transport, highlighting the critical importance of this segment in maintaining product integrity throughout the supply chain.

Segment Analysis: By Product

Branded Drugs Segment in Spain Pharmaceutical Logistics Market

The branded drugs segment dominates the Spanish pharmaceutical logistics market, commanding approximately 79% of the total market share in 2024. This significant market presence is primarily attributed to the segment's strong foothold in hospital prescriptions and physician preferences. The segment's dominance is further reinforced by its established distribution networks and strategic partnerships with major healthcare institutions across Spain. Branded drugs, while being costlier compared to their generic counterparts, maintain their market leadership through robust quality assurance, comprehensive research backing, and established brand trust among healthcare providers. The segment's strength is particularly evident in specialized therapeutic areas and complex drug formulations where brand reputation and proven efficacy play crucial roles in prescription decisions.

Generic Drugs Segment in Spain Pharmaceutical Logistics Market

The generic drugs segment is emerging as the most dynamic sector in the Spanish pharmaceutical logistics market, projected to grow at approximately 6% annually from 2024 to 2029. This accelerated growth is being driven by increasing government initiatives to promote generic drug usage and reduce healthcare costs. The segment is experiencing significant expansion due to the implementation of favorable policies and regulatory frameworks that encourage generic drug adoption. The growth is further supported by the rising awareness among healthcare providers and patients about the cost-effectiveness of generic alternatives. The segment's expansion is also benefiting from improvements in manufacturing capabilities, enhanced distribution networks, and increasing acceptance among healthcare professionals. Two out of every five pills sold in pharmacies today are generic, indicating a strong market penetration trend that is expected to continue throughout the forecast period.

Segment Analysis: By Application

Chemical Pharma Segment in Spain Pharmaceutical Logistics Market

The Chemical Pharma segment dominates the Spanish pharmaceutical logistics market, holding approximately 74% of the market share in 2024. This segment's strong position is supported by Spain's robust chemical industry infrastructure, particularly in regions like Catalonia, which produces roughly 43% of Spain's chemicals. The segment benefits from strategic manufacturing hubs across key locations including Madrid, which houses around 13.5% of production primarily focusing on pharmaceuticals, and Andalusia, which contributes 12.7% of production. The segment encompasses various products including highly specialized and purified chemicals crucial for drug synthesis, active pharmaceutical ingredients (APIs), large-volume basic chemicals like solvents and acids, and non-therapeutic ingredients such as binders and fillers. Spain's chemical sector, comprising over 3,120 companies, provides a strong foundation for this segment's dominance, with significant investments in research and technological development amounting to EUR 2.5 billion annually.

Bio-Pharma Segment in Spain Pharmaceutical Logistics Market

The Bio-Pharma segment is emerging as the fastest-growing segment in the Spanish pharmaceutical logistics market, projected to grow at approximately 5% during 2024-2029. This growth is driven by Spain's expanding biotechnology sector, with over 4,000 biotechnology companies forming an industry where innovation and R&D are key drivers. The segment's growth is further supported by significant investments in biotechnology, which saw record-breaking private investment exceeding EUR 180 million in recent years. Spain's strong research infrastructure, including renowned universities and research institutions such as Pompeu Fabra University and the University of Barcelona, actively contributes to cutting-edge biopharmaceutical research. The segment's expansion is also fueled by the country's increasing focus on personalized medicine, gene therapy, and artificial intelligence-driven drug discovery, supported by various government initiatives including tax breaks and grants for R&D activities.

Spain Pharmaceutical Logistics Industry Overview

Top Companies in Spain Pharmaceutical Logistics Market

The pharmaceutical logistics market in Spain is characterized by continuous innovation and strategic expansion among key players like Logista Pharma, UPS (including Bomi Group), ID Logistics, Movianto, and Alloga. Companies are heavily investing in temperature-controlled facilities and specialized transportation solutions, with a particular focus on expanding frozen and deep-frozen storage capabilities to meet evolving pharmaceutical needs. The industry is witnessing widespread adoption of automation, artificial intelligence, and blockchain technologies to enhance operational efficiency and supply chain visibility. Market leaders are strengthening their positions through strategic acquisitions and partnerships, while simultaneously expanding their geographical footprint and service portfolios. There is also an increasing emphasis on sustainable practices, including the implementation of electric vehicle fleets and energy-efficient warehousing solutions, alongside the development of innovative packaging solutions for maintaining product integrity during transportation.

Fragmented Market with Strong Consolidation Trends

The Spanish pharmaceutical logistics landscape exhibits a relatively fragmented structure, characterized by a mix of global logistics giants and specialized regional players. The market features prominent international companies leveraging their extensive networks and technological capabilities, alongside numerous small and medium-sized local operators who maintain a strong regional presence and specialized service offerings. The industry is experiencing ongoing consolidation through mergers and acquisitions, as larger players seek to expand their capabilities and geographic coverage while smaller specialists focus on niche services and regional expertise. The competitive dynamics are further shaped by the presence of both pure-play pharmaceutical 3PL providers and diversified logistics companies that have developed dedicated healthcare divisions.


The market is witnessing a transformation through vertical integration strategies, with many players expanding their service offerings to include value-added services such as packaging, labeling, and quality control. Global players are increasingly establishing a local presence through acquisitions of regional companies, while local players are forming strategic alliances to compete more effectively. The industry structure is evolving with the entry of technology-driven logistics providers and the expansion of traditional players into specialized pharmaceutical services, creating a more complex and interconnected competitive landscape.

Innovation and Sustainability Drive Future Success

Success in the healthcare logistics market increasingly depends on companies' ability to adapt to evolving industry requirements and technological advancements. Market leaders are focusing on developing comprehensive end-to-end solutions that integrate advanced tracking systems, temperature monitoring capabilities, and regulatory compliance measures. The ability to provide specialized services for different temperature ranges and product types, combined with investments in sustainable practices and digital transformation, has become crucial for maintaining a competitive advantage. Companies are also emphasizing the importance of building strong relationships with pharmaceutical manufacturers and healthcare providers while developing flexible solutions that can accommodate varying customer needs.


Future market success will be significantly influenced by companies' ability to navigate regulatory requirements while maintaining operational efficiency and service quality. Players must focus on developing robust quality management systems, implementing sustainable practices, and investing in employee training and development. The increasing demand for specialized medical logistics services, coupled with growing end-user expectations for transparency and reliability, necessitates continuous innovation in service delivery models. Companies must also consider potential regulatory changes and their impact on operations while maintaining sufficient flexibility to adapt to market changes and emerging opportunities in the pharmaceutical distribution sector.

Spain Pharmaceutical Logistics Market Leaders

  1. DHL

  2. FedEx

  3. Kuehne + Nagel International AG

  4. United Parcel Service

  5. C. H. Robinson

  6. *Disclaimer: Major Players sorted in no particular order
Spain Pharmaceutical Logistics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Spain Pharmaceutical Logistics Market News

  • April 2024: IMCD N.V. (IMCD), a leading distributor of specialty chemicals and ingredients, today announces that IMCD Spain has signed an agreement to acquire 100% of the shares in Cobapharma, a European distributor in the pharmaceutical and nutraceutical industry. This acquisition opens new opportunities for Cobapharma to expand its offerings and reach a broader customer base.
  • July 2024: The Spanish company Esteve Pharmaceuticals is building a manufacturing unit in its Girona plant with the aim to expand its production of active pharmaceutical ingredients (APls). The construction project will be financed until 2026 by a EUR 100 million (USD 108 million) investment by the company. The facilities, slated to begin operations in early 2026, will involve production and service buildings in addition to up to 150 cubic meters of reaction volume. With the new manufacturing facility, Esteve expects its production capacity in the plant to increase by 45%, with an additional 15% growth in its global capacity.

Spain Pharmaceutical Logistics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET INSIGHTS AND DYNAMICS

  • 4.1 Current Market Scenario
  • 4.2 Market Drivers
    • 4.2.1 Increase In Pharmaceutical Sales Is Driving The Market
    • 4.2.2 Rise In Population Is Driving The Market
  • 4.3 Marrket Restraints
    • 4.3.1 Ensure The Safety Of Medications
    • 4.3.2 Labor Shortage
  • 4.4 Market Opportunities
    • 4.4.1 Increase in Cold Storage Warehouses
  • 4.5 Industry Supply Chain/Value Chain Analysis
  • 4.6 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.6.1 Bargaining Power of Suppliers
    • 4.6.2 Bargaining Power of Consumers
    • 4.6.3 Threat of New Entrants
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Intensity of Competitive Rivalry
  • 4.7 Government Initiatives and Regulations in the Market
  • 4.8 Technological Trends in the Market
  • 4.9 Insights Into The 3PL Market in Spain
  • 4.10 Impact of Geopolitics and Pandemic on the Market

5. MARKET SEGMENTATION

  • 5.1 By Services
    • 5.1.1 Transportation
    • 5.1.1.1 Road
    • 5.1.1.2 Rail
    • 5.1.1.3 Air
    • 5.1.1.4 Sea
    • 5.1.2 Storage and Warehousing
    • 5.1.3 Value Added Services
  • 5.2 By Temperature Control
    • 5.2.1 Temperature Controlled/Cold Chain
    • 5.2.2 Non-Temperature Controlled/Non-Cold Chain
  • 5.3 By Product
    • 5.3.1 Generic Drugs
    • 5.3.2 Branded Drugs
  • 5.4 By Application
    • 5.4.1 Biopharma
    • 5.4.2 Chemical Pharma

6. COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration Overview
  • 6.2 Company Profiles
    • 6.2.1 DHL
    • 6.2.2 FedEx
    • 6.2.3 Kuehne+Nagel International AG
    • 6.2.4 United Parcel Service
    • 6.2.5 C.H. Robinson
    • 6.2.6 CEVA Logistics
    • 6.2.7 DB Schenker
    • 6.2.8 Movianto
    • 6.2.9 Agility Logistics
    • 6.2.10 Eurotranspharma
    • 6.2.11 CSP*
  • *List Not Exhaustive
  • 6.3 Other Companies

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

8. APPENDIX

  • 8.1 Macroeconomic Indicators (GDP Distribution, by Activity)
  • 8.2 Economic Statistics - Transport and Storage Sector Contribution to Economy
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Spain Pharmaceutical Logistics Industry Segmentation

Pharmaceutical logistics is concerned with the production, processing, and transportation of materials, as well as the resources and activities associated with the handling of manufactured items by their consumers. Logistics businesses are critical to the operation of any pharmaceutical company.

A comprehensive background analysis of the Spain Pharmaceutical Logistics Market, covering the current market trends, restraints, technological updates, and detailed information on various segments and the competitive landscape of the industry. The impact of COVID-19 has also been incorporated and considered during the study.

Spain's pharmaceutical logistics market is segmented by product (generic drugs, branded drugs), by mode of operation (cold chain logistics, non-cold chain logistics), by application (bio-pharma, chemical pharma), and by mode of transport (air shipping, rail shipping, road shipping, sea shipping). The report offers market size and forecasts for the Spain Pharmaceutical Logistics market in value (usd billion) for all the above segments.

By Services Transportation Road
Rail
Air
Sea
Storage and Warehousing
Value Added Services
By Temperature Control Temperature Controlled/Cold Chain
Non-Temperature Controlled/Non-Cold Chain
By Product Generic Drugs
Branded Drugs
By Application Biopharma
Chemical Pharma
Need A Different Region or Segment?
Customize Now

Spain Pharmaceutical Logistics Market Research FAQs

How big is the Spain Pharmaceutical Logistics Market?

The Spain Pharmaceutical Logistics Market size is expected to reach USD 5.88 billion in 2025 and grow at a CAGR of greater than 4.40% to reach USD 7.29 billion by 2030.

What is the current Spain Pharmaceutical Logistics Market size?

In 2025, the Spain Pharmaceutical Logistics Market size is expected to reach USD 5.88 billion.

Who are the key players in Spain Pharmaceutical Logistics Market?

DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service and C. H. Robinson are the major companies operating in the Spain Pharmaceutical Logistics Market.

What years does this Spain Pharmaceutical Logistics Market cover, and what was the market size in 2024?

In 2024, the Spain Pharmaceutical Logistics Market size was estimated at USD 5.62 billion. The report covers the Spain Pharmaceutical Logistics Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Spain Pharmaceutical Logistics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Spain Pharmaceutical Logistics Market Research

Mordor Intelligence offers a comprehensive analysis of the pharmaceutical logistics and healthcare logistics landscape in Spain. We combine deep industry expertise with detailed market analytics. Our extensive research covers the entire spectrum of pharmaceutical supply chain operations. This includes drug distribution, pharmaceutical warehousing, and pharmaceutical transportation systems. The report provides detailed insights into pharmaceutical delivery networks and pharmaceutical storage facilities. It also examines specialized clinical trial logistics services, offering stakeholders a complete view of Spain's evolving medical logistics sector.

The report, available as an easy-to-download PDF, enables stakeholders to understand critical aspects of pharmaceutical distribution and pharmaceutical supply dynamics. Our analysis encompasses specialized segments such as pharmaceutical cold chain management, vaccine logistics, and pharma 3PL services. The comprehensive coverage includes a detailed examination of pharmaceutical shipping practices, pharmaceutical freight operations, and pharma cold chain infrastructure. These insights are valuable for industry participants looking to optimize their logistics operations in Spain's pharmaceutical sector.